Pharnext S.A. (ENXTPA:ALPHA) announced a private placement of 725,513 shares at a price of 8.35 for gross proceeds of 6,058,000 and 10 convertible bonds at a price of 1,000,000 for gross proceeds of 10,000,000 on April 11, 2018. The convertible bond carries a coupon rate of 6.9%. The maturity date of bonds is 3 years from the date of date of issuance.
The transaction involved participation from Tasly Pharmaceutical Group Co., Ltd. (SHSE:600535) and CB LUX.